Chicken pox – pipeline review, h1 2012


Published on

-Aarkstore EnterpriseChicken Pox – Pipeline Review, H1 2012 || Market Research

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Chicken pox – pipeline review, h1 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Chicken Pox – Pipeline Review, H1 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, Chicken Pox - Pipeline Review, H1 2012, provides anoverview of the Chicken Pox therapeutic pipeline. This report provides informationon the therapeutic development for Chicken Pox, complete with latest updates, andspecial features on late-stage and discontinued projects. It also reviews key playersinvolved in the therapeutic development for Chicken Pox. Chicken Pox - PipelineReview, H1 2012 is built using data and information sourced from Global MarketsDirect’s proprietary databases, Company/University websites, SEC filings, investorpresentations and featured press releases from company/university sites andindustry-specific third party sources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Chicken Pox.- A review of the Chicken Pox products under development by companies anduniversities/research institutes based on information derived from company andindustry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.- A feature on pipeline projects on the basis of monotherapy and combined
  2. 2. therapeutics.Table of contents:List of Tables 4List of Figures 4Introduction 5Global Markets Direct Report Coverage 5Erosive Oral Lichen Planus Overview 6Therapeutics Development 7An Overview of Pipeline Products for Erosive Oral Lichen Planus 7Erosive Oral Lichen Planus Therapeutics under Development by Companies 9Erosive Oral Lichen Planus Therapeutics under Investigation byUniversities/Institutes 10Late Stage Products 11Comparative Analysis 11Mid Clinical Stage Products 12Comparative Analysis 12Pre-Clinical Stage Products 13Comparative Analysis 13Erosive Oral Lichen Planus Therapeutics – Products under Development byCompanies 14Erosive Oral Lichen Planus Therapeutics – Products under Investigation byUniversities/Institutes 15Companies Involved in Erosive Oral Lichen Planus Therapeutics Development 16BioAlliance Pharma SA 16Erosive Oral Lichen Planus – Therapeutics Assessment 17Assessment by Monotherapy Products 17Assessment by Route of Administration 18Assessment by Molecule Type 20Drug Profiles 22Corticosteroid Lauriad - Drug Profile 22Product Description 22Mechanism of Action 22R&D Progress 22Amevive - Drug Profile 23
  3. 3. Product Description 23Mechanism of Action 23List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H1 2012 Review, H12012&PubId=&pagenum=1Vasculitis – Pipeline Review, H1 2012Wrinkles – Pipeline Review, H1 2012Premenstrual Syndrome – Pipeline Review, H1 2012Hypercalcemia – Pipeline Review, H1 2012Chicken Pox – Pipeline Review, H1 2012Hypereosinophilic Syndrome – Pipeline Review, H1 2012Familial Adenomatous Polyposis Coli – Pipeline Review, H1 2012Tinnitus – Pipeline Review, H1 2012Shock – Pipeline Review, H1 2012
  4. 4. Influenza B Infections – Pipeline Review, H1 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: